BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2006
View Archived Issues
Progesterone may be of benefit in treating brain trauma
Read More
PF-670462: new potent CKIe inhibitor evokes phase delays
Read More
RAMP-2 study of ultrasound contrast agent AI-700 completes enrollment
Read More
Preclinical characteristics of HCV protease inhibitor ITMN-191 described
Read More
Emergent and sanofi pasteur sign license agreement for novel meningitis B vaccine
Read More
Milestone in phase II study of Xanafide for secondary AML
Read More
Data from trial of eszopiclone in insomniac patients with depression further analyzed
Read More
Nastech enters into supply agreement with P&G for PTH (1-34) nasal spray
Read More
MTD defined for YM-155 in phase I trial
Read More
Continuous infusion of cilengitide associated with predictable pharmacokinetics
Read More
Results reported at ASCO for GTI-2040 in AML and HRPC
Read More
Second-generation fusion protein from Active Biotech shows activity in NSCLC and RCC
Read More
Denibulin shows promising activity and tolerability profile in advanced cancer patients
Read More
Preliminary results of phase I study of E-7820 discussed at major cancer meeting
Read More
Novel antiinfective agents patented
Read More
Recent patents report new therapeutic agents for metabolic disorders
Read More
Novel therapeutic options for cardiovascular diseases disclosed in recent patents
Read More
Preclinical results suggest NSD-503's potential utility in COPD
Read More
Enrollment opens in phase II study of AL-208 for CABG-associated MCI
Read More
Novartis to acquire NeuTec Pharma
Read More
Disappointing phase II results for oral levosimendan in severe chronic heart failure
Read More
Tanabe Seiyaku and Maruho conclude agreement for topical PDE4 inhibitor
Read More
Orphan drug designation for CellCept for pemphigus vulgaris
Read More
Phase I study for INCB-13739 for type 2 diabetes
Read More
Sirtris completes dosing in phase I study of SRT-501
Read More
Nereus studies NPI-2358 for solid tumors in phase I study
Read More
Serotonin 5-HT6 antagonist PRX-07034 begins phase I study
Read More
Phase II results for AMG-0001
Read More
Gardasil approved by FDA
Read More
Priority review for Zolinza NDA for advanced CTCL
Read More
Cialis Once-A-Day submitted for European review
Read More
Targeting bacterial fatty-acid biosynthesis with platensimycin effective against resistant bacteria
Read More
Phase I/II trials investigate safety, efficacy of [131I]-metuximab injection in liver cancer
Read More